NO955263L - N-substituerte azaheterosykliske karboksylsyrer og estere derav - Google Patents

N-substituerte azaheterosykliske karboksylsyrer og estere derav

Info

Publication number
NO955263L
NO955263L NO955263A NO955263A NO955263L NO 955263 L NO955263 L NO 955263L NO 955263 A NO955263 A NO 955263A NO 955263 A NO955263 A NO 955263A NO 955263 L NO955263 L NO 955263L
Authority
NO
Norway
Prior art keywords
esters
carboxylic acids
substituted azaheterocyclic
azaheterocyclic carboxylic
compounds
Prior art date
Application number
NO955263A
Other languages
English (en)
Other versions
NO955263D0 (no
Inventor
Jesper Lau
Hans Petersen
Knud Erik Andersen
Per Olaf Soerensen
Behrend Friedrich Lundt
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO955263D0 publication Critical patent/NO955263D0/no
Publication of NO955263L publication Critical patent/NO955263L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Terapeutisk aktive, azahetero- sykliske forbindelser med formel (I) >¿\~cox A-(CH2)n-0-(CH2)m - / Y_R3 hvor A er (a), (b) eller (c) R1 N-CH2 (a) R2 R1 CH R1. .C-CH, (c) fremgangsmåte for fremstilling av disse og farmasøytiske preparater som omfat- ter forbindelsene. De nye forbindelsene kan anvendes ved behandling av en sentralnervesystemlidelse relatert til GABA-opptaket.
NO955263A 1993-06-23 1995-12-22 N-substituerte azaheterosykliske karboksylsyrer og estere derav NO955263L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK93746A DK74693D0 (da) 1993-06-23 1993-06-23 Novel heterocyclic chemistry
PCT/DK1994/000253 WO1995000486A1 (en) 1993-06-23 1994-06-22 N-substituted azaheterocyclic carboxylic acids and esters thereof

Publications (2)

Publication Number Publication Date
NO955263D0 NO955263D0 (no) 1995-12-22
NO955263L true NO955263L (no) 1996-02-22

Family

ID=8097063

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955263A NO955263L (no) 1993-06-23 1995-12-22 N-substituerte azaheterosykliske karboksylsyrer og estere derav

Country Status (16)

Country Link
US (1) US5604242A (no)
EP (1) EP0705248A1 (no)
JP (1) JPH08511783A (no)
CN (1) CN1128989A (no)
AU (1) AU7067794A (no)
BG (1) BG100246A (no)
CA (1) CA2165946A1 (no)
CZ (1) CZ335495A3 (no)
DK (1) DK74693D0 (no)
FI (1) FI956177A (no)
HU (1) HUT75303A (no)
IL (1) IL110078A0 (no)
NO (1) NO955263L (no)
SK (1) SK162795A3 (no)
WO (1) WO1995000486A1 (no)
ZA (1) ZA944470B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1506499A (en) * 1997-12-12 1999-07-05 Toyama Chemical Co. Ltd. Alkyl ether derivatives or salts thereof and calcium antagonists containing the same
JP4549452B2 (ja) * 1997-12-12 2010-09-22 富山化学工業株式会社 アルキルエーテル誘導体またはその塩並びにそれらを含有するカルシウム拮抗剤
IL161308A0 (en) 2001-10-19 2004-09-27 Toyama Chemical Co Ltd Alkyl ether derivatives or their salts
CN1382441A (zh) * 2002-05-21 2002-12-04 中国科学院上海生命科学研究院 γ-氨基丁酸转运蛋白抑制剂在制备镇痛药物中的应用
NZ543100A (en) * 2003-04-17 2008-07-31 Toyama Chemical Co Ltd Preventive/remedy for retinal nerve dieases containing alkyl ether derivatives or salts thereof
BRPI0512841A (pt) * 2004-07-02 2008-01-08 Warner Lambert Co composições e métodos para o tratamento de infecções patológicas
DE102006053500A1 (de) 2006-11-14 2008-05-15 Evonik Goldschmidt Gmbh Antimikrobielle Zusammensetzungen
WO2011036713A1 (ja) * 2009-09-24 2011-03-31 株式会社 東芝 二酸化炭素吸収液
AU2018210393A1 (en) 2017-01-20 2019-07-25 The Regents Of The University Of California Inhibitors of the N-terminal domain of the androgen receptor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4910312A (en) * 1985-11-08 1990-03-20 Warner-Lambert Company Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof
DK588189D0 (da) * 1989-11-22 1989-11-22 Novo Nordisk As Nye heterocykliske carboxylsyrer
DK93791D0 (da) * 1991-05-17 1991-05-17 Novo Nordisk As Nye heterocykliske carboxylsyrer

Also Published As

Publication number Publication date
ZA944470B (en) 1995-12-22
US5604242A (en) 1997-02-18
JPH08511783A (ja) 1996-12-10
WO1995000486A1 (en) 1995-01-05
AU7067794A (en) 1995-01-17
IL110078A0 (en) 1994-10-07
NO955263D0 (no) 1995-12-22
HU9503755D0 (en) 1996-02-28
SK162795A3 (en) 1996-09-04
DK74693D0 (da) 1993-06-23
CA2165946A1 (en) 1995-01-05
CN1128989A (zh) 1996-08-14
FI956177A (fi) 1996-02-21
HUT75303A (en) 1997-05-28
CZ335495A3 (en) 1996-07-17
EP0705248A1 (en) 1996-04-10
FI956177A0 (fi) 1995-12-21
BG100246A (en) 1996-07-31

Similar Documents

Publication Publication Date Title
NO962811D0 (no) Nye heterosykliske forbindelser
NO940669L (no) Nye isosteriske peptider
MX9603520A (es) Derivados del acido hidroxamico y acido carboxilico, procesos para su preparacion y su uso.
DE3587151D1 (de) Behandlung von gastrointestinalkrankheiten durch anwendung von 5-ht3-antagonisten.
DK0650960T3 (da) Substituerede heterocykliske carboxylsyreamid-estere, deres fremstilling og deres anvendelse som lægemidler.
PT94869A (pt) Processo de preparacao de uma composicao terapeutica a base de moleculas de anticorpos anti-cd14
NO955263L (no) N-substituerte azaheterosykliske karboksylsyrer og estere derav
MX9707531A (es) Nuevos compuestos heterociclicos.
FI103116B1 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten, N-substituoitujen atsaheterosyklisten karboksyylihappojohdannaisten valmistamiseksi
AU5100296A (en) Novel heterocyclic compounds
DE68912811D1 (de) Amide von Cyclomethylen-1,2 bicarbonsäure mit therapeutischer Wirkung, Verfahren zu deren Herstellung sowie diese enthaltende pharmazeutische Zusammensetzungen.
NO982863L (no) Nye forbindelser med analgetisk effekt
NO955260L (no) N-substituerte azaheterosykliske karboksylsyrer og estere derav
DE69405292D1 (de) 6-Piperazinyl-1H-pyrazolo(3,4-b)pyridin-3-carbonsäuren, ihre Ester, Amide und verwandte Verbindungen, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
AU5100496A (en) Novel heterocyclic compounds
CA2073189A1 (en) N-substituted azaheterocyclic carboxylic acids and a pharmaceutical composition
NO955262L (no) N-substituerte azaheterosykliske karboksylsyrer og estere derav
NO955261L (no) N-substituerte azaheterosykliske karboksylsyrer og estere derav
JPS57197266A (en) Production of 2-aminoglutarimide